OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
58
Views
24
CrossRef citations to date
0
Altmetric
Original Research
Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study
Christian Beisland1 Department of Urology, Haukeland University Hospital;2 Department of Clinical Medicine, University of Bergen, BergenCorrespondence[email protected]
, Tom B Johannesen3 Department of Registration, Cancer Registry of Norway, Oslo
, Olbjorn Klepp4 Department of Oncology, Ålesund Hospital, Ålesund
, Ulrika Axcrona5 Department of Pathology, Oslo University Hospital, the Norwegian Radium Hospital, Oslo
, Knut Martin Torgersen6 Pfizer AS, Oslo, Norway
, Jan Kowalski7 JK Biostatistics AB, Stockholm
, Oddvar Solli6 Pfizer AS, Oslo, Norway
, Rickard Sandin8 Pfizer AB, Sollentuna, Sweden
& Jan Oldenburg9 Department of Oncology, Akershus University Hospital, Lørenskog;10 Medical Faculty, University of Oslo, Oslo, Norway
show all
Pages 371-385
|
Published online: 16 Jan 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.